Skip to main content
. 1998 Aug;42(8):2012–2016. doi: 10.1128/aac.42.8.2012

TABLE 2.

Kinetic properties of meropenem in serum after i.v. administration of 2 g

Patient Cmax (mg/l) AUC (mg · h/liter) CL (ml/min) CL/kg (ml/min/kg) t1/2β (h) Vβ (liter) VSS (liter) VSS/kg
1 90.6 210.6 158 1.86 2.72 37.2 31.9 0.38
2 132.4 305.1 109 1.56 2.34 22.2 19.8 0.28
3 96.1 206.4 162 2.03 1.11 15.5 28.1 0.35
4 80.5 234.3 142 1.89 2.32 28.6 26.4 0.35
5 82.1 91.2 365 4.29 1.32 41.8 24.6 0.29
6 90.6 135.1 247 3.53 1.24 26.5 25.2 0.36
7 56.9 130.0 256 3.20 1.96 43.5 34.5 0.43
8 101.6 97.1 343 3.61 1.01 30.0 19.9 0.21
9 65.6 60.7 549 5.78 1.44 68.7 37.8 0.40
10 51.0 90.2 369 5.68 1.41 45.2 38.9 0.60
 Mean (± SD)a 84.7 (23.7) 156.1 (78.9) 270 (137) 3.34 (1.55) 1.69 (0.60) 35.9 (15.0) 28.7 (6.8) 0.37 (0.10)
 Median 86.4 132.6 252 3.37 1.43 33.6 27.3 0.36
a

SD, standard deviation.